Converse to frequent observations of decreased MHC II expression in tumors are observations of overexpression of EZH2 in diverse tumors types including prostate, breast and bladder cancers and links to enhanced tumor cell proliferation [64], [65], [66]. Here, EZH2 is linked to urinary bladder carcinoma.